The projections come as National Cancer Institute data notes an increase in uterine cancer cases and deaths over the past 30 ...

The FDA rejected investigational oxylanthanum carbonate to treat hyperphosphatemia for chronic kidney disease patients on ...

While incidence and mortality rates for most cancer types have been on the decline in the United States, cases of uterine ...

The aging American population contributes to rising cancer rates across all demographics, but additional factors amplify ...

Uterine cancer rates in the United States are expected to climb significantly over the next 25 years, with Black women ...

About 69,000 new cases and nearly 14,000 deaths are expected this year, according to the American Cancer Society.

Uterine cancer incidence and mortality rates are projected to increase significantly over the next three decades in the ...

Uterine cancer cases and deaths have jumped over the last 30 years. Senate passes Trump’s big bill. Here’s where things stand ...

Incidence and mortality rates for uterine cancer are projected to rise substantially over the next 3 decades, according to research published in Cancer Epidemiology, Biomarkers & Prevention.Racial ...

AstraZeneca secures EU approval for Imfinzi in muscle-invasive bladder cancer, expanding its cancer treatment portfolio.